β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials
Xavier Rosselló(Spanish National Centre for Cardiovascular Research), John Munkhaugen(University of Oslo), Therese Lucia Friis Holmager(Frederiksberg Hospital), Morten Wang Fagerland(Oslo University Hospital), Alberto Domínguez‐Rodríguez(Hospital Universitario de Canarias), Pedro L. Sánchez(Instituto de Investigación Biomédica de Salamanca), Takeshi Kimura(Municipal Hirakata City Hospital), Anna Meta Dyrvig Kristensen(Frederiksberg Hospital), Stuart Pocock(London School of Hygiene & Tropical Medicine), Borja Ibáñez(Spanish National Centre for Cardiovascular Research), Roberto Latini(Mario Negri Institute for Pharmacological Research), Sergio Raposeiras‐Roubín(University Hospital Complex Of Vigo), Filippo Ottani(Ospedale Infermi di Rimini), Sigrun Halvorsen(Oslo University Hospital), Valentı́n Fuster(Mount Sinai Hospital), Dan Atar, Jess Lambrechtsen(Odense University Hospital), Neiko Ozasa(Kyoto University Hospital), Eva Prescott(Frederiksberg Hospital), Arnhild Bakken(Oslo University Hospital), Manuel Anguita(Instituto Maimónides de Investigación Biomédica de Córdoba), Svend Eggert Jensen(Aalborg University Hospital)
Cited by 63
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k